- Home
- DIBS vs IPSC Comparison
DIBS vs IPSC Comparison
Compare DIBS & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIBS
- IPSC
- Stock Information
- Founded
- DIBS 2000
- IPSC 2019
- Country
- DIBS United States
- IPSC United States
- Employees
- DIBS N/A
- IPSC N/A
- Industry
- DIBS Catalog/Specialty Distribution
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- DIBS Consumer Discretionary
- IPSC Health Care
- Exchange
- DIBS Nasdaq
- IPSC Nasdaq
- Market Cap
- DIBS 175.8M
- IPSC 149.1M
- IPO Year
- DIBS 2021
- IPSC 2021
- Fundamental
- Price
- DIBS $3.92
- IPSC $1.24
- Analyst Decision
- DIBS Buy
- IPSC Strong Buy
- Analyst Count
- DIBS 1
- IPSC 4
- Target Price
- DIBS $8.00
- IPSC $13.00
- AVG Volume (30 Days)
- DIBS 107.8K
- IPSC 485.8K
- Earning Date
- DIBS 11-08-2024
- IPSC 11-05-2024
- Dividend Yield
- DIBS N/A
- IPSC N/A
- EPS Growth
- DIBS N/A
- IPSC N/A
- EPS
- DIBS N/A
- IPSC N/A
- Revenue
- DIBS $86,409,000.00
- IPSC $2,684,000.00
- Revenue This Year
- DIBS $5.82
- IPSC $244.52
- Revenue Next Year
- DIBS $7.96
- IPSC $27.73
- P/E Ratio
- DIBS N/A
- IPSC N/A
- Revenue Growth
- DIBS N/A
- IPSC 7.88
- 52 Week Low
- DIBS $3.65
- IPSC $1.14
- 52 Week High
- DIBS $6.30
- IPSC $5.51
- Technical
- Relative Strength Index (RSI)
- DIBS 40.48
- IPSC 39.95
- Support Level
- DIBS $3.65
- IPSC $1.20
- Resistance Level
- DIBS $4.16
- IPSC $1.29
- Average True Range (ATR)
- DIBS 0.14
- IPSC 0.12
- MACD
- DIBS -0.02
- IPSC -0.00
- Stochastic Oscillator
- DIBS 36.49
- IPSC 15.42
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The company's single reportable and operating segment contains two reporting units; 1stDibs, which consists of the company's online marketplace that enables commerce between sellers and buyers; and Design Manager, which is the company's separate online platform that is used to sell a software solution to interior designers. It generates revenue primarily from fees from seller marketplace services as well as other services, including advertisements and software services.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.